Icon Wealth Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $378K | Sell |
1,930
-916
| -32% | -$179K | 0.04% | 202 |
|
|
2023
Q2 | $598K | Sell |
2,846
-389
| -12% | -$81.8K | 0.06% | 174 |
|
|
2023
Q1 | $653K | Buy |
+3,235
| New | +$653K | 0.07% | 170 |
|
|
2022
Q2 | $658K | Sell |
3,076
-396
| -11% | -$84.7K | 0.08% | 175 |
|
|
2022
Q1 | $986K | Sell |
3,472
-32
| -0.9% | -$9.09K | 0.1% | 151 |
|
|
2021
Q4 | $1.32M | Buy |
3,504
+307
| +10% | +$116K | 0.13% | 135 |
|
|
2021
Q3 | $1.32M | Buy |
3,197
+177
| +6% | +$73K | 0.14% | 141 |
|
|
2021
Q2 | $1.12M | Buy |
3,020
+327
| +12% | +$121K | 0.12% | 147 |
|
|
2021
Q1 | $781K | Buy |
+2,693
| New | +$781K | 0.1% | 163 |
|
|
2020
Q3 | – | Sell |
-1,390
| Closed | -$242K | – | 268 |
|
|
2020
Q2 | $242K | Buy |
+1,390
| New | +$242K | 0.06% | 219 |
|
|
2018
Q1 | – | Sell |
-59
| Closed | -$6K | – | 361 |
|
|
2017
Q4 | $6K | Buy |
+59
| New | +$6K | ﹤0.01% | 755 |
|